REDI™ - Regulatory, Equity, Diversity & Inclusion Action Plans

Let us help you comply with REDI requirements for your clinical trials!

Are You REDI?

Regulatory. Equity. Diversity. Inclusion.

REDI™ Planning Committee Leaders

Diversity Plans to Improve Enrollment of Patients

FDA Clinical Trial Diversity

Food and Drug Omnibus Reform Act of 2022

Predictions for the Life Sciences 2024: Regulatory Science

Navigating FDA’s Revised Guidance on SIUU Communications

Collection of Race & Ethnicity Data in Clinical Trials & Clinical Studies for FDA-Regulated Medical Products

Conducting Remote Regulatory Assessments Questions and Answers

A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers

Click the links or scan QR codes

to access the official sources

used in the development of the

REDI™ planning.